Tag Archives: healthcare disinfectants

Clorox Healthcare Enhancements to Bleach Germicidal Disinfectants Announced

NewsSpeaker

In the fight against healthcare-acquired infections (HAIs), today’s healthcare facilities need proven solutions to kill a broad range of infection-causing pathogens, from deadly hospital pathogens like Clostridium difficile (C. difficile) to new threats posed by emerging viral pathogens.

To ensure its disinfectants continue to meet the highest standards of efficacy, Clorox Healthcare voluntarily tested two of its leading ready-to-use bleach disinfectants using updated U.S. Environmental Protection Agency (EPA) recommended standards, which raise the bar for sporicidal disinfectant efficacy.

February 28th, 2017 Clorox Healthcare announced that Clorox Healthcare® Bleach Germicidal Wipes and Clorox Healthcare® Bleach Germicidal Cleaners are now EPA-registered to kill C. difficile spores in three minutes, tested in the presence of a three-part organic soil load,[1] and have gained new disinfection claims for emerging viral pathogens including SARS-associated Coronavirus (SARS-CoV), Middle East Respiratory Syndrome-associated Coronavirus (MERS-CoV) and other common causes of HAIs.

…………………………..>>>>>>

http://www.infectioncontroltoday.com/news/2017/02/clorox-healthcare-announces-enhancements-to-bleach-germicidal-disinfectants.aspx

“At Clorox Healthcare, we are dedicated to safeguarding patient environments and continuously strive to ensure our surface disinfectants meet the needs of the ever-changing healthcare environment,” says Lynda Lurie, Director – Marketing, Clorox Healthcare. “We made these changes proactively so that healthcare professionals can be prepared for whatever comes through their doors, wherever care is delivered.”

…………………….

The new testing standards create a higher challenge for sporicidal disinfectant efficacy. Through voluntary testing, Clorox Healthcare Bleach Germicidal disinfectants have been able to maintain, and in some cases improve, contact times, killing 99.9999 percent of C. difficile spores – the EPA’s required threshold for efficacy – within three minutes, even in the presence of the three-part organic soil load.

[1] Follow special instructions for cleaning prior to disinfection.
[2] Assiri, A, et al. “Hospital Outbreak of Middle East Respiratory Syndrome Coronavirus.” N Engl J Med 2013; 369:407-416. http://www.nejm.org/doi/full/10.1056/NEJMoa1306742#t=article.
[3] Chowell, G, et al. “Transmission Characteristics of MERS and SARS in the Healthcare Setting: a Comparative Study.” BMC Medicine 2015;13:210. https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-015-0450-0.
[4] “List of Pathogens.” World Health Organization. http://www.who.int/csr/research-and-development/list_of_pathogens/en/. (Accessed Feb. 8, 2017).
[5] Otter, JA et al. “Transmission of SARS and MERS Coronaviruses and Influenza Virus in Healthcare Settings: the Possible Role of Dry Surface Contamination.” J. Hosp. Infect. 2016, 92 (3), 235–250.
[6] “Influenza (Flu) Viruses.” U.S. Centers for Disease Control and Prevention. https://www.cdc.gov/flu/about/viruses/index.htm. (Accessed Feb. 8, 2017).
[7] Saint, S, et al. “Clostridium difficile Infection in the United States: A National Study Assessing Preventive Practices Used and Perceptions of Practice Evidence.” Infect. Con¬trol Hosp. Epidemiol. 2015;36.8:969–971.
[8] “Hospital Value-Based Purchasing.” Centers for Medicare & Medicaid Services. https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/hos¬pital-value-based-purchasing. (Accessed Feb. 8, 2017).
[9] “Guidance for the Efficacy Evaluation of Products with Sporicidal Claims Against Clostridium difficile (June 2014).” U.S. Environmental Protection Agency. https://www.epa.gov/pesticide-registration/guidance-efficacy-evaluation-products-sporicidal-claims-against-clostridium#main-content. (Accessed Feb. 8, 2017).

Source: Clorox Healthcare

To read article in its entirety click on the link below:

http://www.infectioncontroltoday.com/news/2017/02/clorox-healthcare-announces-enhancements-to-bleach-germicidal-disinfectants.aspx

*PLEASE NOTE – The C Diff Foundation does not endorse any products and/or clinical study in progress. All website postings are strictly for informational purposes only.

 

 

Integrated Environmental Technologies, Ltd – New EPA Approved Amended Label For Excelyte® Incorporates Kill Claims for Adenovitus,Norovirus,Rhinovirus,Rotavirus

ietlogo3

 

Integrated Environmental Technologies, Ltd. announced that the U.S. Environmental Protection Agency (EPA) approved an amendment to the Company’s master label for its Excelyte® disinfecting solution.

The Company’s new EPA-approved label incorporates kill claims for adenovirus, norovirus, rhinovirus and rotavirus, which are considered non-enveloped viruses

The Company’s amended EPA-approved label for Excelyte® will continue to include previously EPA-approved kill claims for: (i) various pathogens including, but not limited to, Mycobacterium bovis (Tuberculosis), Salmonella enterica, Pseudomonas aeruginosa, Staphylococcus aureus, methicillin-resistant Staphylococcus aureus (MRSA), H1N1 influenza virus (swine flu) and Respiratory Syncytial virus (RSV); (ii)  hospital-acquired pathogens such as Clostridium difficile spores (C. diff) and vancomycin-resistant enterococci (VRE) as well as a carbapenem-resistant enterobacteriaceae (CRE) known as Klebsiella pneumoniae (NDM-1); (iii)  high-risk blood-borne pathogen human immunodeficiency virus (HIV); (iv) the food-borne pathogens Listeria monocytogenes and Escherichia coli (E. coli); and (v) Yeast, Candida albicans.

These viruses have resulted in serious problems for chain restaurants, cruise ships, and other establishments operating in the food, health or hospitality industries.

Non-enveloped viruses are more resistant to disinfectants than enveloped viruses, many of which are already listed on the Company’s master label.  EPA registered hospital disinfectants such as Excelyte® that have claims against non-enveloped viruses are capable of killing both enveloped and non-enveloped viruses on non-porous environmental surfaces.  This group of viruses can cause serious gastrointestinal, stomach, respiratory and eye infections in humans who have been exposed.

Norovirus is highly contagious and is spread through contaminated food, water and environmental surfaces.  Norovirus infections have been an ongoing challenge in the food, healthcare and hospitality industries and recent outbreaks in chain restaurants and cruise lines have underlined the need to eradicate these viral infections.

Although the Company is currently focused on selling Excelyte® to the oil and gas production industry, the amended EPA label will provide increased opportunities for the use of Excelyte® in the food, healthcare and hospitality industries.  The Company continues to seek strategic partners to assist in the development, marketing and distribution of Excelyte® into these markets.

David R. LaVance, the Company’s President and Chief Executive Officer, commented, “We have pursued the addition of these non-enveloped viruses due to the serious and deadly outbreaks that have been reported nationally and internationally over the past few years.  Norovirus, in particular, has caused significant problems for a major fast food chain.  With the increasing ineffectiveness of antibiotics, it is important to use antibacterial products, such as Excelyte®, to eliminate pathogens before they infect people.”

About Integrated Environmental Technologies, Ltd.

Integrated Environmental Technologies, Ltd. is a publicly-traded company that operates through its wholly-owned operating subsidiary, I.E.T., Inc.  All of the Company’s products and services are marketed and sold under the umbrella brand name, EcoTreatments.

The Company markets and sells its anolyte disinfecting solution under the Excelyte® brand name, which is produced by the Company’s proprietary EcaFlo® equipment that utilizes an electrolytic process known as electrochemical activation to reliably produce environmentally responsible solutions for cleaning, sanitizing and disinfecting.

Excelyte® solutions are EPA-registered, hard-surface disinfectants and sanitizers approved for hospital-level use and are also approved for use as a biocide in the oil and gas industry.  The products can be used anywhere there is a need to control bacteria and viruses. 

The Company’s EcaFlo® equipment also produces a cleaning solution that the Company markets under the Catholyte Zero brand name.  Catholyte Zero solutions are environmentally friendly cleansers and degreasers for janitorial, sanitation and food processing uses.  To learn more, visit www.ecotreatments.com.

To read the article in its entirety please click on the following link:

http://money.cnn.com/news/newsfeeds/articles/prnewswire/PH84506.htm